Chronic myelogenous leukemia (CML) is a clonal disease characterized by the presence of the Philadelphia chromosome and resultant BCR-Abl gene fusion with constitutively active tyrosine kinase in >90% of patients. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.